What is AARD's dilution risk score?

AARD has a latest available DilutionScore record of 41/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for AARD, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for AARD?

DilutionWatch tracks 25 SEC filing types for AARD including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect AARD shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For AARD, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for AARD tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for AARD. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

AARD Dilution Risk Score: 41/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

30

💰 Cash Runway

40

📊 Float Risk

40

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for AARD.

🔔 Track AARD — Get forecast alerts →

Market Data

Market Cap$89.67M

Shares Outstanding21.88M

Float10.91M

Cash$73.87M

Debt$336.0K

Short InterestN/A

Institutional Holdings

QoQ: ↓ 8.5% shares (2026Q1 vs prior)

80 institutional holders · 11.14M shares

#1 Decheng Capital LLC 3.92M shares

#2 CITADEL ADVISORS LLC 1.30M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 1.11M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest652.5K

Days to Cover4.5

% of Float6.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual AARD Dilution Snapshot

Aardvark Therapeutics, Inc. (AARD) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for AARD: xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.